To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers
Clinical trial NCT03650075 · COMPLETED
Trial details
- NCT number
- NCT03650075
- Sponsor
- Metagone Biotech Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-25
- Primary completion
- 2019-12-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.